Lifestyle for the BRAin Health - Nutrition and Exercise Training Intervention
LIBRA-NET
1 other identifier
interventional
40
1 country
1
Brief Summary
Due to the increasing incidence of dementia and the lack of causal treatment, non-pharmacological interventions represent an attractive and effective therapeutic strategy of neurodegenerative diseases, such as Alzheimer's disease. The aim of the study is to assess the impact of a supervised 9-month intervention with aerobic-strength training and nutritional counseling compared to cognitive training and stretching on the brain, cognitive and motor functions, metabolism, physical fitnes and plasma markers of neurodegenertion in older adults at increased risk of developing Alzheimer's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedFirst Posted
Study publicly available on registry
May 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
May 29, 2025
May 1, 2025
2.2 years
July 15, 2024
May 22, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Impact on Cognitive Functions
Overall composite score of neuropsychological testing batery (higher score better outcome)
Measurements at the baseline and after 9-month intervention.
Effect of Interventions on Neurodegeneration Markers
Concentration of plasma neurodegeneration marker pTau 217 (in a subpopulation of patients).
Measurements at the baseline and after 9-month intervention
Secondary Outcomes (7)
Computerized Cognitive Tests
Measurements at the baseline and after 9-month intervention.
Well-being
Measurements at the baseline and after 9-month intervention.
Glucose metabolism
Measurements at the baseline and after 9-month intervention.
MRI of the Brain
Measurements at the baseline and after 9-month intervention.
Adherence
Adherence will be recorded during the 9-month intervention period.
- +2 more secondary outcomes
Study Arms (2)
Aerobic-strength training and nutritional counseling
EXPERIMENTALElderly volunteers participating in aerobic-strength training and nutritional counseling.
Cognitive training and stretching.
EXPERIMENTALElderly volunteers participating in cognitive training combined with stretching training.
Interventions
The intervention consists of a structured program that includes aerobic-strength training (1h training, 3 times per week) conducted by professional trainers combined with nutritional counseling.
The intervention consists of a structured program that includes cognitive training combined with stretching training (90mins training, 2x per week).
Eligibility Criteria
You may qualify if:
- Non-smokers
- Signed informed consent
- Presence of subjective or mild cognitive impairment (SCI/aMCI)
- Elevated levels of selected biomarkers confirming the presence of a pathological process characteristic of Alzheimer's disease
- Absence of any psychological, sociological, or geographical factors that could jeopardize participation in the project.
You may not qualify if:
- Presence of severe cardiovascular, liver, or kidney diseases; advanced or poorly controlled diabetes mellitus (HbA1c \>7%), treated with insulin or incretin analogs; cancer or any other severe disease as assessed by the responsible physician. A history of cancer treated with chemotherapy or radiotherapy if within less than 5 years post-treatment.
- Lack of cooperation, inflexible schedule, or problematic transportation.
- Insufficient functional capacity or presence of comorbidities that prevent participation in the training program (assessment by an internist, cardiologist, neurologist, orthopedic specialist, or other relevant specialists).
- Presence of a pacemaker or any metal implants (contraindication for MRI examination), or allergy to local anesthetics (contraindication for muscle biopsy).
- Smoking, alcohol dependence, or addiction to other narcotic substances.
- Stroke or myocardial infarction within the last year.
- Other diseases of the musculoskeletal or nervous system that potentially interfere with the ability to exercise or cognition - such as severe arthritis, Parkinson's disease, significant essential tremor, epilepsy, etc.
- Concurrent participation in another clinical study.
- Therapy with cholinesterase inhibitors unless the patient is on a stable dose.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Biomedical Research Center Slovak Academy of Sciences
Bratislava, Bratislava Region, 84505, Slovakia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbora Ukropcova, Prof.
Biomedical Research Center Slovak Academy of Science
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- ID codes will be provided for the outcomes assessor, without group-specific characterization
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 15, 2024
First Posted
May 22, 2025
Study Start
September 1, 2024
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
May 29, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share